Alembic Pharmaceuticals (NSE:APLLTD) Other Long Term Assets: ₹ Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:APLLTD Alembic Pharmaceuticals Ltd NSE:APLLTD
85 GF Score
Price ₹848.75
GF Value ₹1,104.09
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Alembic Pharmaceuticals Other Long Term Assets?

Alembic Pharmaceuticals NSE:APLLTD +2.39% 85 Other Long Term Assets is ₹ Mil as of Jun. 2026. GuruFocus rates NSE:APLLTD with a GF Score™ of 85/100 and a GF Value™ of ₹1,104.09 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Alembic Pharmaceuticals's other long-term assets for the quarter that ended in Jun. 2026 was ₹ Mil.

Alembic Pharmaceuticals's quarterly other long-term assets increased from Dec. 2025 (₹ Mil) to Mar. 2026 (₹3,815 Mil) but then stayed the same from Mar. 2026 (₹3,815 Mil) to Jun. 2026 (₹ Mil).

Alembic Pharmaceuticals's annual other long-term assets increased from Mar. 2024 (₹3,009 Mil) to Mar. 2025 (₹3,049 Mil) and increased from Mar. 2025 (₹3,049 Mil) to Mar. 2026 (₹3,815 Mil).

Alembic Pharmaceuticals Other Long Term Assets Historical Data

* Premium members only.

The historical data trend for Alembic Pharmaceuticals's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alembic Pharmaceuticals Other Long Term Assets Chart

Alembic Pharmaceuticals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Long Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,035.70 2,061.50 3,009.20 3,048.70 3,814.50

Alembic Pharmaceuticals Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 1,813.40 - 3,814.50 -
NSE:APLLTD
85GF Score
Alembic Pharmaceuticals Ltd NSE:APLLTD
Other Long Term Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alembic Pharmaceuticals Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Frequently Asked Questions Learn more about Other Long Term Assets →
What does a Other Long Term Assets of ₹ Mil mean?
Alembic Pharmaceuticals (NSE:APLLTD) has a Other Long Term Assets of ₹ Mil as of Jun. 2026. Other long-term assets as record on a company's balance sheet not categorized as standard assets. View historical data on Alembic Pharmaceuticals and its competitors.
Is Alembic Pharmaceuticals' Other Long Term Assets too high?
Alembic Pharmaceuticals' current Other Long Term Assets is ₹ Mil. Overall, Alembic Pharmaceuticals has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alembic Pharmaceuticals' Other Long Term Assets compare to ZTS?
Alembic Pharmaceuticals' Other Long Term Assets of ₹ Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long Term Assets for a Drug Manufacturers company?
A good Other Long Term Assets depends on the Drug Manufacturers industry context. However, Other Long Term Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long Term Assets mean?
A high Other Long Term Assets can signal that a stock is expensive relative to its fundamentals. Other long-term assets as record on a company's balance sheet not categorized as standard assets. View historical data on Alembic Pharmaceuticals and its competitors. Alembic Pharmaceuticals's current Other Long Term Assets is ₹ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alembic Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Alembic Pharmaceuticals (NSE:APLLTD) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹1,104.09, compared to a current price of ₹848.75 — trading 23.1% below its estimated fair value. The current Other Long Term Assets is ₹ Mil. Alembic Pharmaceuticals' overall GF Score™ is 85/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long Term Assets calculated?
Other Long Term Assets is calculated from a company's financial statements. For Alembic Pharmaceuticals (NSE:APLLTD), the current Other Long Term Assets is ₹ Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alembic Pharmaceuticals (NSE:APLLTD) Overvalued in 2026?

Based on GuruFocus' analysis, Alembic Pharmaceuticals stock appears to be undervalued. The current stock price of ₹848.75 is trading 23.1% below its estimated GF Value™ of ₹1,104.09. GuruFocus considers Alembic Pharmaceuticals to be Modestly Undervalued.

Key valuation signals for NSE:APLLTD:

  • Other Long Term Assets: ₹ Mil
  • GF Value™: ₹1,104.09 vs. price of ₹848.75 (23.1% below fair value)
  • GF Score™: 85/100 with 3 warning signs

No single metric tells the full story. See the NSE:APLLTD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Alembic Pharmaceuticals Business Description

Other Exchanges 533573:India
Address Alembic Road, Vadodara, GJ, IND, 390 003
Alembic Pharmaceuticals Ltd is a specialty and generic drug manufacturing company. The company focuses on manufacturing and marketing generic pharmaceutical products across the globe. Alembic also operates a branded formulation business that covers a range of therapeutic areas such as dermatology, oncology, ophthalmology, and injectable formulations. The company considers merger and acquisition investment as a potential component of its operational growth for expanding its research, development, manufacturing, and marketing capabilities.
85GF Score

Get the complete analysis for NSE:APLLTD

Other Long Term Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹848.75
Price
₹1,104.09
GF Value